Lauren Sadocha Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3111 Electric Ave, Port Huron, MI 48060 Phone: 810-985-8900 |
Ms. Agnes Anne Bissett, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1209 Richardson St, Port Huron, MI 48060 Phone: 810-984-5156 |
Kelly Ann Cole, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 520 Superior St, Port Huron, MI 48060 Phone: 810-984-4202 |
Mr. James Thomas King Sr., LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 500 10th St, Port Huron, MI 48060 Phone: 810-357-0760 Fax: 810-357-0761 |
Gloria Klinesteker, LLMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2601 13th St, Port Huron, MI 48060 Phone: 810-987-9100 Fax: 810-987-9105 |
News Archive
InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced that it has received 510(k) clearance from the United States Food and Drug Administration to market the LipiScan IVUS Coronary Imaging System. LipiScan IVUS is the first cardiac catheter to combine intravascular ultrasound and near-infrared spectroscopy to help cardiologists identify and characterize the plaques that complicate stenting and are associated with acute coronary events.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostic systems and consumables for use in hospitals and commercial laboratories worldwide and provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the analysis of synovial fluid as a new product application in its Body Fluids Module utilizing its iQ®200 and iRICELL® automated microscopy analyzers.
One of the roadblocks to the eradication of tuberculosis (TB) is the difficulty in identifying patients with latent TB infections (LTBI). Neither the tuberculin skin test (TST) nor interferon-gamma release assays (IGRAs) are capable of distinguishing active from latent infection or predicting the chance of reactivation.
Dasabuvir (trade name Exviera) and the fixed-dose drug combination ombitasvir/paritaprevir/ritonavir (trade name Viekirax) have been available since January 2015 for the treatment of adults with chronic hepatitis C infection. The German Institute for Quality and Efficiency in Health Care had examined their added benefit in a dossier assessment completed in April 2015.
Mayo Clinic and the Swedish medical university Karolinska Institutet will sign a long-term agreement to collaborate on education, research and innovation. The two institutions, recognized for leadership in medical research, training and patient care, will pursue joint investigations in regenerative medicine, individualized medicine, metabolism, neurosciences and aging research.
› Verified 4 days ago